Edwards Lifesciences Aktie
WKN: 936853 / ISIN: US28176E1082
|
20.02.2014 16:16:00
|
Medtronic, Inc. -- Moody's assigns A2 to Medtronic's new sr notes; outlook stable
New York, February 20, 2014 -- Moody's Investors Service assigned an A2 rating to Medtronic, Inc.'s new senior unsecured note offering expected to total $1.5 to $2.0 billion. The rating outlook is stable. Medtronic's existing A2 senior unsecured and Prime-1 short-term ratings remain unchanged. Proceeds will be used to refinance $550 million in bonds that mature in March, and term out short-term borrowings used to fund acquisitions and shareholder initiatives that exceeded available US cash.
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.